跳到正文
原文
STAT 主站· Ed Silverman·· 15 天前AI 评分25

药企协会投入5900万美元搜索广告影响公众看法

STAT+: Pharma’s trade group spent heavily on search ads to sway public opinion

AI 导读

美国制药业游说团体在七年内投入约5900万美元进行搜索广告宣传,试图影响公众对处方药成本的看法。其中,制药研究与制造商协会(PhRMA)花费约3200万美元针对保险和健康计划搜索,另有2800万美元用于批评药房福利管理者,后者被认为是推高药品价格的主要原因。

正文

By Ed Silverman

Nov. 5, 2026

Pharmalot Columnist, Senior Writer

Ed’s stories explore prescription drug pricing, affordability and access, as well issues surrounding patents, litigation, and legislation. He is also the author of the morning Pharmalittle newsletter and the afternoon Pharmalot newsletter.

The lobbying group for the U.S. pharmaceutical industry spent an estimated $59 million on search advertising over a recent seven-year period to influence how Americans view the highly charged issue of prescription drug costs, according to a new analysis that used data to model the spending.

Of that, the Pharmaceutical Research & Manufacturers of America spent roughly $32 million on ads linked to insurance and health plan searches, while $28 million was spent directing people to its web pages and domains criticizing pharmacy benefit managers, which drugmakers argue are the true culprits behind the rising prices for many medicines.

Spending also surged around well-publicized legislative and regulatory actions, such as when Medicare began drug price negotiations in 2023. In all, PhRMA used more than 283,500 distinct keywords to generate 17.1 million paid visits from 2019 through 2025, according to an analysis published in Clinical Pharmacology & Therapeutics.

STAT+ Exclusive Story

Already have an account? Log in

STAT+

STAT+

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and news alerts.

Already have an account? Log in

View All Plans

To read the rest of this story subscribe to STAT+.

来源:STAT 主站 · statnews.com